DLAT, as a Cuproptosis-Related Gene, Regulates Kidney Renal Clear Cell Carcinoma Progression

被引:1
|
作者
Zhang, Peizhi [1 ]
Qiu, Jiechuan [2 ]
Wang, Qingliang [2 ]
Xu, Yingkun [3 ]
Wang, Zicheng [2 ]
Peng, Fan [1 ]
Hao, Yuhu [1 ]
Wu, Guangzhen [4 ]
Xia, Qinghua [1 ,2 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Cheeloo Coll Med, Dept Urol, Jinan 250021, Shandong, Peoples R China
[2] Shandong First Med Univ, Shandong Prov Hosp, Dept Urol, Jinan 250021, Shandong, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing 400042, Peoples R China
[4] Dalian Med Univ, Affiliated Hosp 1, Dept Urol, Dalian 116011, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
kidney renal clear cell carcinoma; dihydrolipidamide s-acetyltransferase; Cuproptosis; The Cancer Genome Atlas; Gene Expression Omnibus; PYRUVATE-DEHYDROGENASE COMPLEX; CANCER; AXIS;
D O I
10.23812/j.biol.regul.homeost.agents.20233703.128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cuproptosis is a novel discovered cell death mechanism in cancers. This study aimed to investigate the expression and prognostic value of DLAT (dihydrolipidamide s-acetyltransferase), one of the Cuproptosis-related genes, in kidney renal clear cell carcinoma (KIRC) using a comprehensive analysis integrating bioinformatics and experimental assays.Methods: High-throughput data and clinical information of KIRC patients were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. We used various R packages and bioinformatics analysis websites to analyze DLAT expression and function. Clinical tissue samples were used to verify DLAT expression in KIRC based on real-time quantitative reverse transcription (qRT-PCR) and immunohistochemistry. Subsequently, we validated DLAT differential expression in normal renal cells versus different KIRC cell lines using qRT-PCR. CCK-8 (cell counting kit-8) assay was used to assess the effect of DLAT overexpression on KIRC cells proliferation. Wound healing and Transwell assays were used to assess the effect of DLAT overexpression on KIRC cells invasion and migration.Results: DLAT mRNA expression in KIRC tumor tissue was lower than in normal kidney tissue. DLAT high expression suggested a good prognosis in KIRC. Gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that DLAT was involved in a variety of biological functions and pathways. Infiltration analysis indicated that DLAT might affect the prognosis of KIRC by affecting immune infiltration in the KIRC tumor microenvironment. qRT-PCR and immunohistochemistry further DLAT low expression in KIRC compared to normal kidney tissue. Besides, we found that DLAT overexpression could not only inhibit KIRC cells growth, but also effectively inhibit the migration and invasion of KIRC cell lines.Conclusions: This study explored the expression of DLAT in KIRC and the effect of DLAT on the proliferation, migration, and invasion of renal cancer cell lines, which has a positive role in guiding the diagnosis and treatment of KIRC.
引用
收藏
页码:1267 / 1283
页数:17
相关论文
共 50 条
  • [1] Cuproptosis-related LINC01711 promotes the progression of kidney renal clear cell carcinoma
    Zhang, Houliang
    Zhang, Yifan
    Gao, Liu
    Song, Wei
    Zhang, Haipeng
    Yang, Guangcan
    Wang, Yidi
    Ni, Jinliang
    Wang, Keyi
    Wang, Guangchun
    Mao, Weipu
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (06): : 2617 - 2629
  • [2] Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification
    Huang, Shuaishuai
    Cai, Congbo
    Zhou, Kena
    Wang, Xue
    Wang, Xue
    Cen, Dong
    Weng, Guobin
    AGING-US, 2023, 15 (21): : 12314 - 12329
  • [3] A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma
    Mei, Wangli
    Liu, Xiang
    Jia, Xuyang
    Jin, Liang
    Xin, Shiyong
    Sun, Xianchao
    Zhang, Jiaxin
    Zhang, Bihui
    Chen, Yilai
    Che, Jianping
    Ma, Weiguo
    Ye, Lin
    FRONTIERS IN GENETICS, 2022, 13
  • [4] Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma
    Luo, Gang
    Wang, Lini
    Zheng, Ziyu
    Gao, Baobao
    Lei, Chong
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [5] Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma
    Gang Luo
    Lini Wang
    Ziyu Zheng
    Baobao Gao
    Chong Lei
    European Journal of Medical Research, 28
  • [6] Identification of cuproptosis-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma
    He, Ya
    Zhang, Hongxia
    Li, Jingang
    Zhou, Hui
    Wang, Fei
    Zhang, Guangliang
    Wen, Yuetao
    JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2024, 22 (01):
  • [7] A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma
    Bian, Zilong
    Fan, Rong
    Xie, Lingmin
    GENES, 2022, 13 (05)
  • [8] A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
    Xin, Sheng
    Mao, Jiaquan
    Cui, Kai
    Li, Qian
    Chen, Liang
    Li, Qinyu
    Tu, Bocheng
    Liu, Xiaming
    Wang, Tao
    Wang, Shaogang
    Liu, Jihong
    Song, Xiaodong
    Song, Wen
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [9] Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis
    Li, Ding
    Wu, Xuan
    Song, Wenping
    Cheng, Cheng
    Hao, Lidan
    Zhang, Wenzhou
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (22)
  • [10] Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
    Huili, Youlong
    Nie, Shiwen
    Zhang, Liguo
    Yao, Anliang
    Liu, Jian
    Wang, Yong
    Wang, Lei
    Cao, Fenghong
    FRONTIERS IN GENETICS, 2022, 13